Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb;10(2):220-229.
doi: 10.1530/EC-20-0552.

Free testosterone and cardiometabolic parameters in men: comparison of algorithms

Affiliations

Free testosterone and cardiometabolic parameters in men: comparison of algorithms

Stine A Holmboe et al. Endocr Connect. 2021 Feb.

Abstract

Objective: Calculating the free testosterone level has gained increasing interest and different indirect algorithms have been suggested. The objective was to compare free androgen index (FAI), free testosterone estimated using the linear binding model (Vermeulen: cFTV) and the binding framework accounting for allosterically coupled SHBG monomers (Zakharov: cFTZ) in relation to cardiometabolic conditions.

Design: A prospective cohort study including 5350 men, aged 30-70 years, participating in population-based surveys (MONICA I-III and Inter99) from 1982 to 2001 and followed until December 2012 with baseline and follow-up information on cardiometabolic parameters and vital status.

Results: Using age-standardized hormone levels, FAI was higher among men with baseline cardiometabolic conditions, whereas cFTV and cFTZ levels were lower compared to men without these conditions as also seen for total testosterone. Men in highest quartiles of cFTV or cFTZ had lower risk of developing type 2 diabetes (cFTV: HR = 0.74 (0.49-1.10), cFTZ: HR = 0.59 (0.39-0.91)) than men in lowest quartile. In contrast, men with highest levels of FAI had a 74% (1.17-2.59) increased risk of developing type 2 diabetes compared to men in lowest quartile.

Conclusion: The association of estimated free testosterone and the studied outcomes differ depending on algorithm used. cFTV and cFTZ showed similar associations to baseline and long-term cardiometabolic parameters. In contrast, an empiric ratio, FAI, showed opposite associations to several of the examined parameters and may reflect limited clinical utility.

Keywords: follow-up study; free testosterone; metabolic syndrome; total testosterone.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(A) Free testosterone according to Vermeulen equation plotted against the level according to Zakharov equation (Pearson coefficient r = 0.9, P < 0.01). The line represents the identity line. (B) Bland–Altman plot of the absolute difference between free testosterone calculated by Zakharov and Vermeulen equation (cFTZ – cFTV) according to mean levels of free testosterone calculated by the two equations.
Figure 2
Figure 2
Hazard ratios and 95% CIs for quartiles of free testosterone stratified according to algorithm (FAI, Vermeulen or Zakharov) in relation to type 2 diabetes, ischemic heart disease, cardiovascular disease mortality and all-cause mortality. All models are stratified according to smoking status and adjusted for study, BMI, alcohol consumption and physical exercise with age as the underlying time scale.

References

    1. Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H.Position statement: utility, limitations, and pitfalls in measuring testosterone: an endocrine society position statement. Journal of Clinical Endocrinology and Metabolism 2007. 92 405–413. (10.1210/jc.2006-1864) - DOI - PubMed
    1. Mendel CM.The free hormone hypothesis: a physiologically based mathematical model. Endocrine Reviews 1989. 10 232–274. (10.1210/edrv-10-3-232) - DOI - PubMed
    1. Travison TG, Araujo AB, Kupelian V, O’Donnell AB, McKinlay JB.The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men. Journal of Clinical Endocrinology and Metabolism 2007. 92 549–555. (10.1210/jc.2006-1859) - DOI - PubMed
    1. Wu FCW, Tajar A, Beynon JM, Pye SR, Silman AJ, Finn JD, O’Neill TW, Bartfai G, Casanueva FF, Forti G.et al. Identification of late-onset hypogonadism in middle-aged and elderly men. New England Journal of Medicine 2010. 363 123–135. (10.1056/NEJMoa0911101) - DOI - PubMed
    1. Antonio L, Wu FCW, O’Neill TW, Pye SR, Ahern TB, Laurent MR, Huhtaniemi IT, Lean MEJ, Keevil BG, Rastrelli G.et al. Low free testosterone is associated with hypogonadal signs and symptoms in men with normal total testosterone. Journal of Clinical Endocrinology and Metabolism 2016. 101 2647–2657. (10.1210/jc.2015-4106) - DOI - PubMed

LinkOut - more resources